Interventional • Clinical benefit

EMMA

Clinical benefit

110

Patients enrolled in the program

3

Participating center(s) across the study

Study description

A multicentric, prospective, randomize, longitudinal study: impact of the telemonitoring on therapeutic observance in patient with hematologic cancer treated with oral therapy.

Key results

First patient in: May 2025

Research collaboration

Discuss this study with our research team

Questions about methodology, results, or potential collaborations — our team is available to engage with researchers, clinicians and life sciences partners.